SCHEMBL19543750

SCHEMBL19543750

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)oc4ccccc45)cc3)c3ccc(-c4cccc5oc6ccccc6c45)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ HCRTR1 O43613 1/20 0.39
▸ AHR P35869 2/20 0.39
▸ PLA2G2A P14555 4/20 0.38
▸ PLA2G4A P47712 4/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ALOX5 P09917 1/20 0.37
▸ PLA2G10 O15496 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ PRKDC P78527 2/20 0.35
▸ TNKS O95271 2/20 0.34
▸ BACE1 P56817 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24710056 1.00 MMP12 (0.40) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL24710871 0.97 PLA2G2A (0.41) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL22733196 0.97 AHR (0.41) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL24710379 0.97 AHR (0.41) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL19543752 0.96 HCRTR1 (0.39) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL27381037 0.96 PLA2G2A (0.39) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL17721426 0.95 AHR (0.39) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL17721410 0.95 AHR (0.39) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL17721409 0.95 AHR (0.39) MMP12MMP13HCRTR1AHRPLA2G2A
SCHEMBL24710890 0.94 ALOX5 (0.47) MMP12MMP13HCRTR1AHRPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225006-A2 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2023-08-09 — — EP disclosed
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 — — US disclosed
EP-3246963-A2 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2017-11-22 — — EP disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 — — US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MMP12 2675/4885MMP13 3487/4885HCRTR1 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback